Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome;Tratamiento exitoso de hepatitis autoinmune y síndrome de Evans con rituximab

Revista Medica de Chile

Volumn 139, Issue 11, 2011, Pages 1484-1487

  Carey, Elizabeth J ^a   Somaratne, Krishni ^a   Rakela, Jorge ^a  

^a MAYO CLINIC   (United States)

Author keywords

Anemia; Autoimmune; Evans syndrome; Hemolytic; Hepatitis; Rituximab

Indexed keywords

ASPARTATE AMINOTRANSFERASE; MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE HEPATITIS; BLOOD; CASE REPORT; FEMALE; HUMAN; THROMBOCYTOPENIA;

ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ASPARTATE AMINOTRANSFERASES; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; THROMBOCYTOPENIA;

EID: 84856895586     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872011001100015     Document Type: Article

References (15)

1. Álvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
2. Patel T, Nystrom J, Pyrsopoulos N. Autoimmune hepatitis as a part of polyglandular autoimmune syndrome type II: Case report and literature review. Digest Dis Sci 2010; 55: 861-4.
3. Czaja AJ. Treatment strategies in autoimmune hepatitis. Clin Liver Dis 2002; 6: 799-824.
4. Czaja AJ. Current and future treatments of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol 2009; 3: 269-91.
5. Czaja AJ, Rakela J, Ludwig J. Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 1988; 95: 448-53.
6. Koulova L, Alexandrescu D, Dutcher JP, O'Boyle KP, Eapen S, Wiernik PH. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): Report of three cases. Am J Hematol 2005; 78: 49-54.
7. Ruckert A, Glimm H, Lubbert M, Grullich C. Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up. Lupus 2008; 17:757-60.
8. Santos ES, Arosemena LR, Raez LE, O'Brien C, Regev A. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature. Liver Internat 2006; 26: 625-9.
9. Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, et al. Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 2007; 146: 25-33.
10. Kittaka K, Dobashi H, Baba N, Iseki A, Kameda T, Susaki K, et al. A case of Evan's syndrome combined with systemic lupus erythematosus successfully treated with rituximab. Scand J Rheumatol 2008; 37: 390-3.
11. Silverman GJ, Weisman S. Rituximab therapy and autoimmune disorders: Prospects for anti-B cell therapy. Arthritis Rheum 2003; 48: 1484-92.
12. Reale L, Besa E. Rituximab in autoimmune pancytopenia: a case report and review of literature. Ann Hematol 2007; 86: 913-6.
13. Annicchiarico BE, Siciliano M, Avolio AW, Agnes S, Bombardieri G. Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: A case report. Transplantation Proc 2009; 41: 1380-2.
14. Leandro MJ, Edwards JCW, Cambridge G. Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheumat Dis 2002; 61: 883-8.
15. Sanz I, Anolik JH, Looney RJ. B cell depletion therapy in autoimmune diseases. Front Biosci 2007; 12: 2546-67.